Diagnostics
DNA Repair Capacity Identified Those at High Risk for Non-melanoma Skin Cancer
October 1, 2010 2:34 pm | by AACR | News | CommentsMIAMI — DNA repair capacity (DRC) measurements effectively identified individuals who were at high risk for non-melanoma skin cancer, and may be a useful method to evaluate the efficacy of preventive therapies, according to study results presented at the Third AACR Conference on the...
Vigorous Exercise Reduces Breast Cancer Risk in African-American Women
October 1, 2010 2:33 pm | by AACR | News | CommentsMIAMI — Vigorous exercise of more than two hours per week reduces the risk of developing breast cancer in postmenopausal African-American women by 64 percent, compared to women of the same race who do not exercise, according to researchers at Georgetown Lombardi Comprehensive Cancer Center.
Memory Impairment Common in People with a History of Cancer
October 1, 2010 2:33 pm | by AACR | News | CommentsMIAMI — People with a history of cancer have a 40 percent greater likelihood of experiencing memory problems that interfere with daily functioning, compared with those who have not had cancer, according to results of a new, large study.
Low Socioeconomic Status Linked With More Severe Colorectal Cancer
October 1, 2010 2:33 pm | by AACR | News | CommentsMIAMI — People living in economically deprived neighborhoods were more likely to be diagnosed with late-stage, non-localized colorectal cancer, even after researchers controlled for known colorectal cancer risk factors, according to data presented at the Third American Association for...
Breast Cancer Linked to Environmental Smoke Exposure Among Mexican Women
October 1, 2010 2:33 pm | by AACR | News | CommentsMIAMI — Mexican women who do not smoke but are exposed to smoking, known as environmental smoke exposure, are at three times higher risk for breast cancer than non-smoking women not exposed to passive smoking, according to findings presented at the Third AACR Conference on The Science of...
Multipronged Intervention Treated Persistent Fatigue Effectively in Breast Cancer Survivors
October 1, 2010 2:32 pm | by AACR | News | CommentsMIAMI — A group-based, holistic, mind-body intervention was equally effective in treating persistent fatigue and improving quality of life for breast cancer survivors, regardless of their race.
Adults in Puerto Rico Aware of Genetic Testing, But Use Remains Low
October 1, 2010 2:32 pm | by AACR | News | CommentsMIAMI — Awareness of genetic testing was higher among adults in Puerto Rico compared to previous U.S. population-based studies, while use of genetic testing was lower, according to data presented at the Third AACR Conference on the Science of Cancer Health Disparities, held Sept. 30 to Oct 3, 2010.
BD to Establish Major Distribution Center in Four Oaks, North Carolina
October 1, 2010 7:32 am | by Becton, Dickinson and Company | News | Comments(October 01, 2010) -- BD (Becton, Dickinson and Company), a leading global medical technology company, today announced plans to construct a new East Coast distribution center in Four Oaks, North Carolina. The $38 million investment project is expected to generate n
California gets landmark radiologist dose reporting law
September 30, 2010 3:32 pm | by Diagnostic Imaging | News | CommentsCalifornia radiologists will be required to incorporate radiation dose levels in their reports under a measure signed into law Thursday by Gov. Arnold Schwarzenegger. The measure requires that radiologists include in their reports the dose length product or the CT dose index if the...
Solos Endoscopy, Inc. Announces Results of 2010 Annual Shareholder Meeting
September 30, 2010 8:32 am | by Bio-Medicine.Org | News | CommentsBOSTON, Sept. 30 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce the results of the 2010 annual shareholder meeting held September 28, 2010 near Solos' headquarters in Boston, MA. During Solos' annual shareholder meeting, Robert Segersten, Amanda Segersten and Fred...
Reportlinker Adds Global Immunoassay Systems Industry
September 30, 2010 8:31 am | by Bio-Medicine.Org | News | CommentsNEW YORK, Sept. 30 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Immunoassay Systems Industry http://www.reportlinker.com/p0305127/Global-Immunoassay-Systems-Industry... This report analyzes the worldwide markets for Immunoassay...
2010 Molecular Diagnostics Press Conference Recording
September 29, 2010 8:34 am | by AACR | News | CommentsProgram Chairperson Gordon B. Mills, M.D., Ph.D., chair of the department of systems biology at the University of Texas MD Anderson Cancer Center hosted a press conference on some of the new diagnostic methods under development on Sept. 28, at 1:00 p.m. MT.
NOVAVAX to Present at BIO Investor Forum
September 29, 2010 8:33 am | by Bio-Medicine.Org | News | CommentsROCKVILLE, Md., Sept. 29 /- Novavax, Inc. (Nasdaq: NVAX ) a clinical-stage biopharmaceutical company, announced today that Mr. Frederick Driscoll, Chief Financial Officer of Novavax, will be presenting at the BIO Investor Forum. The presentation will take place on Wednesday, October 6,...
PositiveID Corporation Withdraws Offer to Purchase All Outstanding Shares of Digital Angel Corporation
September 29, 2010 8:33 am | by PositiveID | News | CommentsPositiveID Corporation Withdraws Offer to Purchase All Outstanding Shares of Digital Angel Corporation
NINDS awards new Udall Centers for Parkinson's Disease Research
September 29, 2010 4:33 am | by EurekAlert | News | Comments(NIH/National Institute of Neurological Disorders and Stroke) The NINDS has established two new sites as part of the Morris K. Udall Centers of Excellence in Parkinson's Disease Research: Emory University in Atlanta and the Feinstein Institute for Medical Research in Manhasset, N.Y.
Nanotechnology Brings Personalized Therapy One Step Closer to Reality
September 28, 2010 4:32 pm | by AACR | News | CommentsDENVER — A novel technology can make nanoscale protein measurements, which scientists can use in clinical trials to learn how drugs work.
c-Met May Be a Biomarker for Metastatic Hepatocellular Carcinoma
September 28, 2010 3:31 pm | by AACR | News | CommentsTweet • c-Met activation linked with poor prognosis. • c-Met was highly overexpressed in metastatic liver cancer cells. DENVER — Targeting c-Met may be a promising personalized treatment method for approximately 45 percent of patients with hepatocellular carcinoma (HCC) who have...
New Biomarkers Discovered for Pancreatic Cancer and Mesothelioma
September 28, 2010 12:31 pm | by AACR | News | CommentsDENVER — Using a novel aptamer-based proteomics array technology, researchers and collaborators have identified biomarkers and protein signatures that are hallmarks of cancer at an early stage for two of the most aggressive and deadly forms of cancer — pancreatic and mesothelioma.
Researchers use CT to predict heart disease
September 27, 2010 11:31 pm | by EurekAlert | News | Comments(Radiological Society of North America) Using incidental findings from routine diagnostic CT, radiologists may be better able to identify people at high risk for cardiovascular disease, according to a new study.
Nominations Open for 2011 Scientific Achievement Awards
September 27, 2010 12:31 pm | by AACR | News | CommentsPHILADELPHIA — The American Association for Cancer Research is currently accepting nominations for the following awards, which will be presented at the AACR 102nd Annual Meeting 2011 in Orlando, Fla., from April 2 to 6. The nomination deadline for the awards below is Oct. 15, 2010.
Partners of breast cancer patients are at risk of developing mood disorders
September 27, 2010 9:31 am | by EurekAlert | News | Comments(Wiley-Blackwell) A new analysis finds that men whose partners have breast cancer are at increased risk of developing mood disorders that are so severe that they warrant hospitalization.
eCardio Ranked as One of Houston's Fastest Growing Companies
September 27, 2010 9:31 am | by Bio-Medicine.Org | News | CommentsHOUSTON, Sept. 27 /- Announced Friday, eCardio was included on the Houston Business Journal's Fast 100, which honors 100 of the fastest growing companies in the Houston area. eCardio was ranked at No. four with a two-year growth of 305.23%. "eCardio is privileged to be recognized...
2010 AAO-HNSF new research daily highlights: Monday, Sept. 27, 2010
September 27, 2010 6:31 am | by EurekAlert | News | Comments(American Academy of Otolaryngology -- Head and Neck Surgery) Featuring more than 305 scientific research sessions, 594 posters, and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover breaking...
Launch of Novel Agents for the Treatment of Hepatitis C Virus Will Precipitate Treatment of At Least Half of 'Warehoused' Patients
September 27, 2010 6:31 am | by Bio-Medicine.Org | News | CommentsBURLINGTON, Mass., Sept. 27 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch of novel therapies for the treatment of Hepatitis C Virus (HCV), including Vertex/Johnson & Johnson/Mitsubishi...
The Colorado Institute for Drug, Device and Diagnostic Development Announces Companies Selected From Its First Solicitation: Sophono, Inc., Receiving $600K; and PeptiVir, Inc....
September 27, 2010 6:30 am | by Bio-Medicine.Org | News | CommentsAURORA, Colo., Sept. 27 /- The Colorado Institute for Drug, Device and Diagnostic Development (CID4) has completed the selection process from its first solicitation announced in February. The announcement is made by Richard C. Duke, Ph.D., CID4 President/CEO, who says,...
